Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.23.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Total revenues $ 26,070 $ 16,735
Costs and expenses:    
Cost of product sales 977 121
Research and development 10,089 15,474
Selling, general and administrative 27,729 27,401
Total costs and expenses 38,795 42,996
Loss from operations (12,725) (26,261)
Interest income 393 21
Interest expense (1,204) (1,205)
Net loss $ (13,536) $ (27,445)
Net loss per share, basic (in dollars per share) $ (0.08) $ (0.16)
Net loss per share, diluted (in dollars per share) $ (0.08) $ (0.16)
Weighted average shares used in computing net loss per share, basic (in shares) 173,568 171,774
Weighted average shares used in computing net loss per share, diluted (in shares) 173,568 171,774
Product sales, net    
Total revenues $ 23,745 $ 16,197
Contract revenues from collaborations    
Total revenues $ 2,325 $ 538